Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents.

By J. A. Frank, Bradley R. Miller, A. Arbab, Holly A. Zywicke, E. Jordan, B. Lewis, L. Bryant, J. Bulte. Radiology, 2003

663 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In vivo imaging platform for tracking immunotherapeutic cells (2005, background): “We note that transfection agents are also effective at delivering SPIO nanoparticles into weakly phagocytic stem cell”
Nanoparticles: pharmacological and toxicological significance (2007, background): “The stem cells can ingest the nanoparticles by endocytosis, which results in the intracellular accumulation of nanoparticles that can exert a local effect for detection in vivo (Frank et al., 2003; Kraitchman et al., 2003).”
Synthesis and applications of nano-structured iron oxides/hydroxides - a review (2011, background): “…in finding suitable biomedical applications of versatile iron oxides in the nano scale both for drug release and drug delivery (Kubo et al., 2001; Frank et al., 2003; Gonzales et al., 2005; Cengelli et al., 2006; Aslam et al., 2007; Naka et al., 2008; Piao et al., 2008; Guo et al., 2009;…”